Daewoong releases orally disintegrating tablet, Harunosin D (tamsulosin) tablet

Published: 2010-03-05 06:56:00

Updated: 2010-03-05 06:56:00

Daewoong Pharm announced on March 2 that it has marketed Harunosin D (tamsulosin) tablet, a dosage form for the treatment for functional symptoms of benign prostatic hyperplasia (BPH) in Korea.

Harunosin D tablet can be ingested without water since it quickly disintegrates upon contact with sa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK